FRACTYL HEALTH INC (GUTS) Fundamental Analysis & Valuation

NASDAQ:GUTS • US35168W1036

Current stock price

0.46 USD
-0.01 (-2.09%)
At close:
0.4508 USD
-0.01 (-2%)
Pre-Market:

This GUTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GUTS Profitability Analysis

1.1 Basic Checks

  • GUTS had negative earnings in the past year.
  • In the past year GUTS has reported a negative cash flow from operations.
  • GUTS had negative earnings in each of the past 5 years.
  • GUTS had a negative operating cash flow in each of the past 5 years.
GUTS Yearly Net Income VS EBIT VS OCF VS FCFGUTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • GUTS's Return On Assets of -106.94% is on the low side compared to the rest of the industry. GUTS is outperformed by 81.91% of its industry peers.
Industry RankSector Rank
ROA -106.94%
ROE N/A
ROIC N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GUTS Yearly ROA, ROE, ROICGUTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

  • GUTS's Gross Margin of 100.00% is amongst the best of the industry. GUTS outperforms 100.00% of its industry peers.
  • GUTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GUTS Yearly Profit, Operating, Gross MarginsGUTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. GUTS Health Analysis

2.1 Basic Checks

  • GUTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GUTS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GUTS Yearly Shares OutstandingGUTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
GUTS Yearly Total Debt VS Total AssetsGUTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • GUTS has an Altman-Z score of -8.12. This is a bad value and indicates that GUTS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -8.12, GUTS is not doing good in the industry: 77.66% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.12
ROIC/WACCN/A
WACC7.78%
GUTS Yearly LT Debt VS Equity VS FCFGUTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • A Current Ratio of 4.27 indicates that GUTS has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 4.27, GUTS is doing good in the industry, outperforming 67.55% of the companies in the same industry.
  • A Quick Ratio of 4.27 indicates that GUTS has no problem at all paying its short term obligations.
  • GUTS has a better Quick ratio (4.27) than 73.40% of its industry peers.
Industry RankSector Rank
Current Ratio 4.27
Quick Ratio 4.27
GUTS Yearly Current Assets VS Current LiabilitesGUTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GUTS Growth Analysis

3.1 Past

  • GUTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.26%.
EPS 1Y (TTM)-20.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.54%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • GUTS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.23% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y62.3%
EPS Next 2Y29.34%
EPS Next 3Y21.34%
EPS Next 5Y18.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GUTS Yearly Revenue VS EstimatesGUTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 100M 200M 300M 400M
GUTS Yearly EPS VS EstimatesGUTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. GUTS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GUTS. In the last year negative earnings were reported.
  • Also next year GUTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GUTS Price Earnings VS Forward Price EarningsGUTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GUTS Per share dataGUTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GUTS's earnings are expected to grow with 21.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.34%
EPS Next 3Y21.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GUTS Dividend Analysis

5.1 Amount

  • GUTS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GUTS Fundamentals: All Metrics, Ratios and Statistics

FRACTYL HEALTH INC

NASDAQ:GUTS (4/10/2026, 8:28:26 PM)

Premarket: 0.4508 -0.01 (-2%)

0.46

-0.01 (-2.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-24
Earnings (Next)05-12
Inst Owners72.9%
Inst Owner Change0%
Ins Owners1.32%
Ins Owner Change0.09%
Market Cap72.98M
Revenue(TTM)N/A
Net Income(TTM)-122.20M
Analysts83.64
Price Target5.34 (1060.87%)
Short Float %3.94%
Short Ratio0.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.75%
Min EPS beat(2)-120.28%
Max EPS beat(2)-55.23%
EPS beat(4)0
Avg EPS beat(4)-48.37%
Min EPS beat(4)-120.28%
Max EPS beat(4)-0.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)1.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 24326.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.84
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -106.94%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100%
FCFM N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 73.35%
Cap/Sales 26233.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.27
Quick Ratio 4.27
Altman-Z -8.12
F-Score2
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)132.87%
Cap/Depr(5y)81.29%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.54%
EPS Next Y62.3%
EPS Next 2Y29.34%
EPS Next 3Y21.34%
EPS Next 5Y18.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.49%
EBIT Next 3Y5.25%
EBIT Next 5Y23.95%
FCF growth 1Y-93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.21%
OCF growth 3YN/A
OCF growth 5YN/A

FRACTYL HEALTH INC / GUTS Fundamental Analysis FAQ

What is the fundamental rating for GUTS stock?

ChartMill assigns a fundamental rating of 2 / 10 to GUTS.


What is the valuation status for GUTS stock?

ChartMill assigns a valuation rating of 1 / 10 to FRACTYL HEALTH INC (GUTS). This can be considered as Overvalued.


How profitable is FRACTYL HEALTH INC (GUTS) stock?

FRACTYL HEALTH INC (GUTS) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for GUTS stock?

The Earnings per Share (EPS) of FRACTYL HEALTH INC (GUTS) is expected to grow by 62.3% in the next year.